Literature DB >> 16227066

Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse.

Ayrn D O'Connor1, Daniel E Rusyniak, Askiel Bruno.   

Abstract

Alcohol and stimulant abuse represents a major cause of cerebrovascular and cardiovascular disease in young adults. Although mild-to-moderate alcohol consumption has been linked to a decreased risk for stroke and CVD, excessive use is associated with an increased risk for intracranial hemorrhage and cardiomyopathy. Cocaine represents the single largest,cause of medical complications related to illegal drug use. Cocaine has been associated with cerebral infarction, intracranial hemorrhage, myocardial infarction, cardiomyopathy, and cardiac arrhythmias. Abuse of amphetamines is associated with complications similar to those of cocaine. The complications associated with stimulant abuse are thought to be primarily mediated through excess catecholamines, resulting in acute arterial hypertension, vasospasm, thrombosis, and accelerated atherosclerosis. Because many complications of alcohol and stimulant abuse are preventable and reversible, it is important to screen for these in patients with cerebrovascular and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227066     DOI: 10.1016/j.mcna.2005.06.010

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  15 in total

1.  Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.

Authors:  Derong Ding; Justin R Nickell; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2015-05-09       Impact factor: 2.823

2.  The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress.

Authors:  Daniel E Rusyniak; Dmitry V Zaretsky; Maria V Zaretskaia; Pamela J Durant; Joseph A DiMicco
Journal:  Physiol Behav       Date:  2012-02-14

Review 3.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

4.  Acceleration of cardiovascular-biological age by amphetamine exposure is a power function of chronological age.

Authors:  Albert Stuart Reece; Amanda Norman; Gary Kenneth Hulse
Journal:  Heart Asia       Date:  2017-01-10

5.  Trends in substance abuse preceding stroke among young adults: a population-based study.

Authors:  Felipe de los Ríos; Dawn O Kleindorfer; Jane Khoury; Joseph P Broderick; Charles J Moomaw; Opeolu Adeoye; Matthew L Flaherty; Pooja Khatri; Daniel Woo; Kathleen Alwell; Jane Eilerman; Simona Ferioli; Brett M Kissela
Journal:  Stroke       Date:  2012-11-15       Impact factor: 7.914

Review 6.  Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Authors:  Daniel Ciccarone
Journal:  Prim Care       Date:  2011-01-11       Impact factor: 2.907

Review 7.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11

Review 8.  Medical comorbidity and alcohol dependence.

Authors:  Paolo Mannelli; Chi Un Pae
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

9.  Orexinergic neurotransmission in temperature responses to methamphetamine and stress: mathematical modeling as a data assimilation approach.

Authors:  Abolhassan Behrouzvaziri; Daniel Fu; Patrick Tan; Yeonjoo Yoo; Maria V Zaretskaia; Daniel E Rusyniak; Yaroslav I Molkov; Dmitry V Zaretsky
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

10.  Neurological soft signs in individuals with pathological gambling.

Authors:  Igor Elman; Tamara V Gurvits; Evelyne Tschibelu; Justin D Spring; Natasha B Lasko; Roger K Pitman
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.